| Bioactive compounds of citrus fruits: A review of composition and health benefits of carotenoids, flavonoids, limonoids, and terpenes RK Saini, A Ranjit, K Sharma, P Prasad, X Shang, KGM Gowda, YS Keum Antioxidants 11 (2), 239, 2022 | 186 | 2022 |
| Update on angiotensin II subtype 2 receptor: focus on peptide and nonpeptide agonists A Ranjit, S Khajehpour, A Aghazadeh-Habashi Molecular pharmacology 99 (6), 469-487, 2021 | 11 | 2021 |
| YS Keum Bioactive compounds of citrus fruits: A review of composition and health benefits of carotenoids, flavonoids, limonoids, and terpenes., 2022, 11, 239 RK Saini, A Ranjit, K Sharma, P Prasad, X Shang, KGM Gowda DOI: https://doi. org/10.3390/antiox11020239, 0 | 5 | |
| Anti-Inflammatory Effects of Ang-(1-7) Bone-Targeting Conjugate in an Adjuvant-Induced Arthritis Rat Model S Khajeh pour, A Ranjit, EL Summerill, A Aghazadeh-Habashi Pharmaceuticals 15 (9), 1157, 2022 | 3 | 2022 |
| Prevention and treatment of rheumatoid arthritis using bone‐targeted angiotensin peptide in rats AA Habashi, SA Khajeh pour, A Ranjit The FASEB Journal 34 (S1), 1-1, 2020 | 2 | 2020 |
| Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis A Ranjit, S Khajeh pour, A Aghazadeh-Habashi Pharmaceutics 14 (8), 20, 2022 | 1 | 2022 |
| Novel treatment option for rheumatoid arthritis through bone‐targeted delivery of Novokinin A Ranjit, S Khajehpour, A Aghazadeh‐Habashi The FASEB Journal 36, 2022 | 1 | 2022 |
| Bone-Targeted Delivery of Novokinin, an Angiotensin II Type 2 Receptor Agonist, for Improved Pharmacokinetics and Therapeutic Effects A Ranjit Idaho State University, 2023 | | 2023 |
| Khajeh pour, S.; Aghazadeh-Habashi, A. Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis. Pharmaceutics 2022, 14, 1681 A Ranjit s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Bioactive compounds of citrus fruits: A review of composition and health benefits of carotenoids, flavonoids, limonoids, and terpenes. Antioxidants. 2022; 11 (2): 239 RK Saini, A Ranjit, K Sharma, P Prasad, X Shang, KGM Gowda, YS Keum s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| Deletion of Arid1a in osteosarcoma enhances aggressive cell phenotypes K Fatema, A Ranjit, J Barrott, A Habashi The FASEB Journal 33 (S1), 790.5-790.5, 2019 | | 2019 |
| Stem cell therapy: an emerging technology in the field of Medicine SR Shah, K Harikumar, A Ranjit International Journal of Novel Trends in Pharmaceutical Sciences 5 (6), 222-226, 2015 | | 2015 |
